Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Research in Pharmacology and Drug Discovery|January 6, 2022
Unmet needs in inflammatory bowel diseaseJoana Revés, Ryan C Ungaro, Joana Torres
GE Portuguese Journal of Gastroenterology|April 2, 2025
Positive <i>Yersinia</i> Serology and Colonic Cobblestone Pattern: A Diversion or Main Culprit?Joana Revés, Catarina Frias-Gomes, Lídia Roque Ramos, et al.
Inflammatory Bowel Diseases|June 23, 2026
Importance of higher infliximab trough level maintenance compared with the HLA-DQA1*05 polymorphism in preventing anti-infliximab antibodies and loss of response to infliximabJoana Revés, Ana Guedes, Ana Catarina Bravo, et al.
GE Portuguese Journal of Gastroenterology|October 3, 2024
Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced PatientsJoana Revés, Ana Catarina Bravo, Catarina Neto Nascimento, et al.
Journal of Crohn'S & Colitis|May 23, 2023
Early intervention with biologic therapy in Crohn´s disease: how early is early?Joana Revés, André Mascarenhas, Maria José Temido, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2026
Use of Intestinal Ultrasound in a Tight monitoring approach in Crohn's disease: a multicentre prospective studyCarolina Palmela, Joana Revés, Catarina Frias-Gomes, et al.
Therapeutic Advances in Gastroenterology|June 30, 2025
Real-life management of nonobstructive esophageal dysphagia: analysis of a prospective multicentric Portuguese cohortRaquel R Mendes, José Pedro Rodrigues, Inês Simão, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 6, 2025
Manometric and clinical characterization of non-obstructive esophageal dysphagia focusing on its impact on quality of lifeJosé Pedro Rodrigues, Raquel R Mendes, André Mascarenhas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Early Biological Therapy Within 12 Months of Diagnosis Leads to Higher Transmural Healing Rates in Crohn's DiseaseJoana Revés, Agnes Fernandez-Clotet, Ingrid Ordás, et al.
Nature Immunology|July 30, 2024
A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycanJoana Gaifem, Cláudia S Rodrigues, Francesca Petralia, et al.
Pageof 2